3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
NETWORK
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Multiple Myeloma
192
Lymphoma
102
Lymphoma, Non-Hodgkin
90
Leukemia, Myeloid, Acute
89
Precursor Cell Lymphoblastic Leukemia-Lymphoma
81
Myelodysplastic Syndromes
81
Hodgkin Disease
67
Leukemia
66
Neoplasms, Plasma Cell
65
Lymphoma, Large B-Cell, Diffuse
59
Leukemia, Lymphocytic, Chronic, B-Cell
58
Lymphoma, Mantle-Cell
52
Lymphoma, Follicular
49
Burkitt Lymphoma
39
Lymphoma, Large-Cell, Immunoblastic
35
Lymphoma, B-Cell, Marginal Zone
34
Myeloproliferative Disorders
30
Recurrence
28
Hematologic Neoplasms
28
Neuroblastoma
25
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
25
Leukemia, Myeloid, Accelerated Phase
24
Graft vs Host Disease
23
Leukemia, Myelomonocytic, Chronic
22
Leukemia, Myeloid, Chronic-Phase
22
Congenital Abnormalities
21
Immunoglobulin Light-chain Amyloidosis
20
Dendritic Cell Sarcoma, Interdigitating
19
Primary Myelofibrosis
18
Waldenstrom Macroglobulinemia
17
Interventions
Rituximab
5
fludarabine
4
Tacrolimus
4
Epoetin Alfa
4
Cyclophosphamide
4
Busulfan
4
Darbepoetin alfa
3
Alemtuzumab
3
fludarabine phosphate
2
entrectinib
2
atezolizumab
2
alectinib
2
Thiotepa
2
Therapeutics
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Methotrexate
2
Etoposide
2
Early Intervention, Educational
2
Cytarabine
2
Bortezomib
2
Antilymphocyte Serum
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
venetoclax
1
trametinib
1
tirbanibulin
1
sargramostim
1
plerixafor
1
phenethyl isothiocyanate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoproliferative Disorders
×
Melphalan
×
Clear all
NCT02366663
2018-03-12
SPINOZA
City of Hope Medical Center
Phase 3
Terminated
3 enrolled
8 charts